Israel diagnostic imaging market is anticipated to grow significantly during the projected period of 2028 that is driven by the increasing refractive disorders and technological advancements in medical industries.
Rising Cases of Chronic Diseases is Booming the Israel Diagnostic Imaging Market
The prevalence of chronic diseases in Israel has been on the rise in recent years, mainly due to changing lifestyles, aging population, and increasing urbanization. According to the Israel Ministry of Health, in 2019, approximately 64% of deaths in Israel were attributed to chronic diseases, with cancer and cardiovascular diseases being the leading causes of death. The burden of chronic diseases not only affects the quality of life of individuals but also imposes a significant economic burden on the healthcare system. As a result, there has been a growing demand for advanced diagnostic imaging technologies in Israel to facilitate early and accurate diagnosis of chronic diseases, monitor disease progression, and guide treatment decisions. This has led to a booming market for diagnostic imaging in Israel, with a wide range of modalities being utilized, including X-ray, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and nuclear medicine.
Rising Technological Advancements and Innovations in the Production Process of Medical Devices
Recent Development
In July 2021, AllianceRx Walgreens Prime, one of the biggest specialty and home delivery pharmacies in the US, announced a partnership with Israeli company TailorMed, which has developed a financial navigation technology platform to assist healthcare organizations in removing financial barriers to care. By streamlining the process of connecting eligible patients with financial resources, TailorMed's platform will assist the organization in lessening the burden of specialty therapies for those patients.
In May 2022, at the 69th Annual Conference of the Israel Heart Society, Sheba Medical Centre Israel and UltraSight, an Israeli digital health pioneer transforming cardiac imaging through the power of artificial intelligence, presented new research findings from a blinded pilot study, which validate the company's technology and demonstrate that any medical professional can successfully capture high-quality cardiac ultrasound images with the help of UltraSight's AI guidance.
Market Segmentation
The Israel diagnostic imaging market is segmented into type, mobility, modality, source,
Company Profiles
TailorMed, 270 Surgical, DiA Imaging Analysis Ltd., Sheba Medical Center, LensFree, Applied Spectral Imaging, Applitec Ltd., Arineta Ltd., Aspect Imaging, and Cintec Medical Ltd are some of the key players of the Israel diagnostic imaging market.
Attribute | Details |
Base Year | 2022 |
Historic Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million, Volume in tons and CAGR for 2018-2022 and 2023-2028 |
Report coverage | Revenue forecast, volume forecasting, Company shares, competitive landscape, growth factors, and trends |
Segments covered | Type Mobility Modality Source Application End User Component |
Country scope | The Mediterranean Coastal Plain, The Central Hills, The Jordan Rift Valley, and The Negev Desert. |
Key companies profiled | TailorMed, 270 Surgical, DiA Imaging Analysis Ltd., Sheba Medical Center, LensFree, Applied Spectral Imaging, Applitec Ltd., Arineta Ltd., Aspect Imaging, and Cintec Medical Ltd |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |